BioGaia AB (publ) (LON:0GTN)

London flag London · Delayed Price · Currency is GBP · Price in SEK
128.15
-0.04 (-0.03%)
At close: Feb 21, 2025
2.92%
Market Cap 954.89M
Revenue (ttm) 102.68M
Net Income (ttm) 25.36M
Shares Out n/a
EPS (ttm) 0.25
PE Ratio 37.65
Forward PE n/a
Dividend 0.51 (0.38%)
Ex-Dividend Date May 8, 2024
Volume 20,537
Average Volume 5,894
Open 127.90
Previous Close 128.19
Day's Range 127.00 - 129.30
52-Week Range 6.94 - 9.88
Beta 0.58
RSI 58.66
Earnings Date Feb 12, 2025

About BioGaia AB

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment provides packaging solutions. It sells its pro... [Read more]

Industry Pharmaceutical Preparations
Founded 1990
Employees 225
Stock Exchange London Stock Exchange
Ticker Symbol 0GTN
Full Company Profile

Financial Performance

In 2024, BioGaia AB's revenue was 1.42 billion, an increase of 9.73% compared to the previous year's 1.30 billion. Earnings were 351.39 million, a decrease of -3.82%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.